Mint Labs, Inc., d/b/a. QMENTA

Company profile

About Mint Labs, Inc., d/b/a. QMENTA

QMENTA (Mint Labs, Inc.) is a medical imaging AI platform that serves as the infrastructure layer connecting drug development, clinical research, and diagnostic imaging. The company specializes in neuroimaging and provides an end-to-end solution for managing, analyzing, and quantifying medical imaging data across clinical trials, research studies, and clinical care settings. Founded by neuroscientists, QMENTA offers three main product lines: Trials (for GxP-compliant clinical studies), Foundation (for AI development and deployment), and Legal (for traumatic brain injury litigation support). The platform processes over 16 million images across 1.3 million subjects at 250+ imaging sites worldwide. QMENTA's technology enables real-time quality control, automated AI analysis, central review capabilities, and regulatory-grade data management compliant with FDA 21 CFR Part 11 and EMA standards. The platform supports multiple imaging modalities including MRI, PET, CT, OCT, and EEG, with particular expertise in CNS disorders, neuro-oncology, multiple sclerosis, Alzheimer's disease, and neuropsychiatric conditions. Key differentiators include 75% reduction in reading time, 50% total cost reduction, zero nonconformities in external pharma audits, and the ability to accelerate research-to-clinical-practice timelines from the industry norm of 10+ years to five years, as demonstrated by the CAVS-MS study. The company maintains dual headquarters in Boston and Barcelona, serving pharmaceutical sponsors, CROs, core labs, AI firms, academic centers, hospitals, imaging centers, and law firms.

Company description · Mint Labs, Inc., d/b/a. QMENTA official website